Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 17, 2024

SELL
$92.27 - $101.54 $45,673 - $50,262
-495 Reduced 18.37%
2,199 $222,000
Q3 2023

Oct 17, 2023

SELL
$94.73 - $105.13 $2,841 - $3,153
-30 Reduced 1.1%
2,694 $274,000
Q2 2023

Jul 13, 2023

BUY
$92.52 - $104.91 $9,437 - $10,700
102 Added 3.89%
2,724 $274,000
Q1 2023

Apr 19, 2023

SELL
$80.03 - $92.81 $27,210 - $31,555
-340 Reduced 11.48%
2,622 $241,000
Q4 2022

Feb 14, 2023

SELL
$75.55 - $92.52 $50,618 - $61,988
-670 Reduced 18.45%
2,962 $268,000
Q3 2022

Nov 02, 2022

SELL
$74.61 - $87.26 $39,916 - $46,684
-535 Reduced 12.84%
3,632 $276,000
Q2 2022

Jul 26, 2022

SELL
$80.52 - $93.75 $59,987 - $69,843
-745 Reduced 15.17%
4,167 $352,000
Q1 2022

May 02, 2022

SELL
$80.11 - $90.62 $19,386 - $21,930
-242 Reduced 4.7%
4,912 $431,000
Q4 2021

Feb 01, 2022

BUY
$79.7 - $88.13 $1,115 - $1,233
14 Added 0.27%
5,154 $450,000
Q3 2021

Oct 20, 2021

BUY
$81.78 - $95.14 $18,891 - $21,977
231 Added 4.71%
5,140 $420,000
Q2 2021

Aug 12, 2021

BUY
$85.24 - $94.15 $1,704 - $1,883
20 Added 0.41%
4,909 $447,000
Q1 2021

Apr 29, 2021

BUY
$83.5 - $98.47 $20,457 - $24,125
245 Added 5.28%
4,889 $417,000
Q4 2020

Feb 09, 2021

SELL
$78.07 - $94.43 $16,004 - $19,358
-205 Reduced 4.23%
4,644 $438,000
Q3 2020

Oct 23, 2020

BUY
$82.14 - $91.0 $11,088 - $12,285
135 Added 2.86%
4,849 $421,000
Q2 2020

Aug 11, 2020

BUY
$80.93 - $91.1 $2,832 - $3,188
35 Added 0.75%
4,714 $411,000
Q1 2020

May 06, 2020

BUY
$70.67 - $99.01 $330,664 - $463,267
4,679 New
4,679 $385,000
Q4 2019

Feb 10, 2020

SELL
$84.35 - $95.37 $517,993 - $585,667
-6,141 Closed
0 $0
Q3 2019

Oct 30, 2019

BUY
$85.54 - $94.26 $1,710 - $1,885
20 Added 0.33%
6,141 $525,000
Q2 2019

Aug 13, 2019

BUY
$75.4 - $92.8 $8,294 - $10,208
110 Added 1.83%
6,121 $558,000
Q1 2019

May 01, 2019

BUY
$75.32 - $86.15 $452,748 - $517,847
6,011 New
6,011 $577,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Patriot Investment Management Inc. Portfolio

Follow Patriot Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Patriot Investment Management Inc. with notifications on news.